On ECHEMI
Home > Drugs > Extrapulmonary tuberculosis
Extrapulmonary tuberculosis
Extrapulmonary tuberculosis refers to the tuberculosis bacteria infecting the respiratory system and causing people to suffer from pulmonary tuberculosis. It can also spread from lung lesions to various organs of the human body through the blood or lymphatic system. Tuberculosis occurs in various parts of the body other than the lungs. At present, the clinical treatment of common extrapulmonary tuberculosis has made significant progress, especially the progress of chemotherapy, which has saved many patients with extrapulmonary tuberculosis who need surgical treatment from the pain of surgery. At the same time, the improvement of surgical methods and strong chemotherapy after surgery have improved the effect and safety of surgery and reduced postoperative recurrence. Although extrapulmonary tuberculosis is generally not contagious, it can cause pain and serious harm to people, and it should also be taken seriously, so as to achieve early detection and adhere to reasonable chemotherapy throughout the course.
  • Site of disease:

    lung
  • Infectious :

    Contagious
  • Frequent population:

    All groups
  • Related symptoms:

Related Drugs
Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

Harbin Pharmaceutical Group Pharmaceutical Factory No.6

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

GRAND PHARMACEUTICAL(China) Co., Ltd.

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

Hunan Er-Kang Pharmaceutical Co., Ltd.

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd.

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

Jiangxi Pharmaceutical Co., Ltd.

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

Southwest Pharmaceutical Co., Ltd.

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Sodium p-aminosalicylate tablets
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance to this product, so it must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.